25 XP   0   0   10

Ckd Bio
Buy, Hold or Sell?

Let's analyse Ckd Bio together

PenkeI guess you are interested in Ckd Bio. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Ckd Bio. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Ckd Bio

I send you an email if I find something interesting about Ckd Bio.

Quick analysis of Ckd Bio (30 sec.)










What can you expect buying and holding a share of Ckd Bio? (30 sec.)

How much money do you get?

How much money do you get?
₩0.00
When do you have the money?
1 year
How often do you get paid?
90.0%

What is your share worth?

Current worth
₩22,425.33
Expected worth in 1 year
₩4,361.03
How sure are you?
60.0%

+ What do you gain per year?

Total Gains per Share
₩-18,064.30
Return On Investment
-77.0%

For what price can you sell your share?

Current Price per Share
₩23,450.00
Expected price per share
₩22,600 - ₩25,850
How sure are you?
50%

1. Valuation of Ckd Bio (5 min.)




Live pricePrice per Share (EOD)

₩23,450.00

Intrinsic Value Per Share

₩-60,855.64 - ₩79,867.61

Total Value Per Share

₩-38,430.32 - ₩102,292.94

2. Growth of Ckd Bio (5 min.)




Is Ckd Bio growing?

Current yearPrevious yearGrowGrow %
How rich?$86.1m$103.4m-$17.3m-20.1%

How much money is Ckd Bio making?

Current yearPrevious yearGrowGrow %
Making money-$16.9m-$11.6m-$5.2m-31.0%
Net Profit Margin-15.1%-10.7%--

How much money comes from the company's main activities?

3. Financial Health of Ckd Bio (5 min.)




What can you expect buying and holding a share of Ckd Bio? (5 min.)

Welcome investor! Ckd Bio's management wants to use your money to grow the business. In return you get a share of Ckd Bio.

What can you expect buying and holding a share of Ckd Bio?

First you should know what it really means to hold a share of Ckd Bio. And how you can make/lose money.

Speculation

The Price per Share of Ckd Bio is ₩23,450. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Ckd Bio.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Ckd Bio, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ₩22,425.33. Based on the TTM, the Book Value Change Per Share is ₩-4,516.07 per quarter. Based on the YOY, the Book Value Change Per Share is ₩-2,495.80 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ₩0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Ckd Bio.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 % of Price per Share% of Price per Share% of Price per Share% of Price per Share% of Price per Share
Usd Eps-3.090.0%-3.090.0%-2.130.0%-0.740.0%0.020.0%
Usd Book Value Change Per Share-3.160.0%-3.160.0%-1.750.0%-0.630.0%-0.010.0%
Usd Dividend Per Share0.000.0%0.000.0%0.070.0%0.090.0%0.140.0%
Usd Total Gains Per Share-3.160.0%-3.160.0%-1.680.0%-0.530.0%0.120.0%
Usd Price Per Share16.70-16.70-16.66-27.84-21.99-
Price to Earnings Ratio-5.41--5.41--7.82-7.14--0.81-
Price-to-Total Gains Ratio-5.28--5.28--9.93-0.00--1.31-
Price to Book Ratio1.06-1.06-0.88-1.40-1.17-
Price-to-Total Gains Ratio-5.28--5.28--9.93-0.00--1.31-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share16.415
Number of shares60
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.09
Usd Book Value Change Per Share-3.16-0.63
Usd Total Gains Per Share-3.16-0.53
Gains per Quarter (60 shares)-189.68-32.06
Gains per Year (60 shares)-758.70-128.25
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-759-76923-151-138
20-1517-152845-302-266
30-2276-228768-453-394
40-3035-304691-604-522
50-3794-3805113-754-650
60-4552-4564136-905-778
70-5311-5323159-1056-906
80-6070-6082181-1207-1034
90-6828-6841204-1358-1162
100-7587-7600226-1509-1290

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%0.03.00.00.0%2.03.00.040.0%6.04.00.060.0%12.04.00.075.0%
Book Value Change Per Share0.01.00.00.0%0.03.00.00.0%2.03.00.040.0%6.04.00.060.0%11.05.00.068.8%
Dividend per Share0.00.01.00.0%2.00.01.066.7%4.00.01.080.0%9.00.01.090.0%15.00.01.093.8%
Total Gains per Share0.01.00.00.0%0.03.00.00.0%2.03.00.040.0%6.04.00.060.0%12.04.00.075.0%

Fundamentals of Ckd Bio

About Ckd Bio

CKD Bio Corp. engages in the manufacturing and sale of pharmaceutical products in South Korea, Europe, Asia, the Middle East, and internationally. The company is also involved in real estate leasing and related ancillary; bio, cosmetics, and health functional food; property management; advertising communication; consulting, construction, and maintenance of corporate IT systems business. It also exports its products. The company was founded in 1941 and is headquartered in Seoul, South Korea.

Fundamental data was last updated by Penke on 2024-04-15 10:22:04.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Ckd Bio.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Ckd Bio earns for each ₩1 of revenue.

  • Above 10% is considered healthy but always compare Ckd Bio to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of -15.1% means that ₩-0.15 for each ₩1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Ckd Bio:

  • The MRQ is -15.1%. The company is making a huge loss. -2
  • The TTM is -15.1%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-15.1%TTM-15.1%0.0%
TTM-15.1%YOY-10.7%-4.4%
TTM-15.1%5Y-3.3%-11.8%
5Y-3.3%10Y1.0%-4.3%
1.1.2. Return on Assets

Shows how efficient Ckd Bio is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Ckd Bio to the Drug Manufacturers - Specialty & Generic industry mean.
  • -8.2% Return on Assets means that Ckd Bio generated ₩-0.08 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Ckd Bio:

  • The MRQ is -8.2%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -8.2%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-8.2%TTM-8.2%0.0%
TTM-8.2%YOY-5.3%-2.9%
TTM-8.2%5Y-1.7%-6.6%
5Y-1.7%10Y0.9%-2.6%
1.1.3. Return on Equity

Shows how efficient Ckd Bio is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Ckd Bio to the Drug Manufacturers - Specialty & Generic industry mean.
  • -19.7% Return on Equity means Ckd Bio generated ₩-0.20 for each ₩1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Ckd Bio:

  • The MRQ is -19.7%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -19.7%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-19.7%TTM-19.7%0.0%
TTM-19.7%YOY-11.3%-8.4%
TTM-19.7%5Y-4.7%-14.9%
5Y-4.7%10Y-0.1%-4.6%

1.2. Operating Efficiency of Ckd Bio.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Ckd Bio is operating .

  • Measures how much profit Ckd Bio makes for each ₩1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Ckd Bio to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of 0.0% means the company generated ₩0.00  for each ₩1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Ckd Bio:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-9.5%+9.5%
TTM-5Y0.0%+0.0%
5Y0.0%10Y4.5%-4.6%
1.2.2. Operating Ratio

Measures how efficient Ckd Bio is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 2.08 means that the operating costs are ₩2.08 for each ₩1 in net sales.

Let's take a look of the Operating Ratio trends of Ckd Bio:

  • The MRQ is 2.076. The company is inefficient in keeping operating costs low. -1
  • The TTM is 2.076. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ2.076TTM2.0760.000
TTM2.076YOY1.987+0.088
TTM2.0765Y1.878+0.198
5Y1.87810Y1.819+0.059

1.3. Liquidity of Ckd Bio.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Ckd Bio is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 1.13 means the company has ₩1.13 in assets for each ₩1 in short-term debts.

Let's take a look of the Current Ratio trends of Ckd Bio:

  • The MRQ is 1.133. The company is just able to pay all its short-term debts.
  • The TTM is 1.133. The company is just able to pay all its short-term debts.
Trends
Current periodCompared to+/- 
MRQ1.133TTM1.1330.000
TTM1.133YOY1.513-0.380
TTM1.1335Y1.739-0.606
5Y1.73910Y2.300-0.561
1.3.2. Quick Ratio

Measures if Ckd Bio is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Ckd Bio to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 0.35 means the company can pay off ₩0.35 for each ₩1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Ckd Bio:

  • The MRQ is 0.346. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.346. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.346TTM0.3460.000
TTM0.346YOY0.416-0.070
TTM0.3465Y0.580-0.235
5Y0.58010Y0.881-0.300

1.4. Solvency of Ckd Bio.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Ckd Bio assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Ckd Bio to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.58 means that Ckd Bio assets are financed with 58.1% credit (debt) and the remaining percentage (100% - 58.1%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Ckd Bio:

  • The MRQ is 0.581. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.581. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.581TTM0.5810.000
TTM0.581YOY0.527+0.054
TTM0.5815Y0.459+0.123
5Y0.45910Y0.347+0.112
1.4.2. Debt to Equity Ratio

Measures if Ckd Bio is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Ckd Bio to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 138.8% means that company has ₩1.39 debt for each ₩1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Ckd Bio:

  • The MRQ is 1.388. The company is able to pay all its debts with equity. +1
  • The TTM is 1.388. The company is able to pay all its debts with equity. +1
Trends
Current periodCompared to+/- 
MRQ1.388TTM1.3880.000
TTM1.388YOY1.115+0.273
TTM1.3885Y0.901+0.487
5Y0.90110Y0.605+0.296

2. Market Valuation of Ckd Bio

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ₩1 in earnings Ckd Bio generates.

  • Above 15 is considered overpriced but always compare Ckd Bio to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of -5.41 means the investor is paying ₩-5.41 for every ₩1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Ckd Bio:

  • The EOD is -5.318. Based on the earnings, the company is expensive. -2
  • The MRQ is -5.408. Based on the earnings, the company is expensive. -2
  • The TTM is -5.408. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-5.318MRQ-5.408+0.091
MRQ-5.408TTM-5.4080.000
TTM-5.408YOY-7.817+2.409
TTM-5.4085Y7.143-12.551
5Y7.14310Y-0.813+7.956
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Ckd Bio:

  • The EOD is -7.146. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -7.268. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -7.268. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-7.146MRQ-7.268+0.122
MRQ-7.268TTM-7.2680.000
TTM-7.268YOY-12.513+5.245
TTM-7.2685Y-8.242+0.974
5Y-8.24210Y-10.743+2.501
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Ckd Bio is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A PB ratio of 1.06 means the investor is paying ₩1.06 for each ₩1 in book value.

Let's take a look of the Price to Book Ratio trends of Ckd Bio:

  • The EOD is 1.046. Based on the equity, the company is underpriced. +1
  • The MRQ is 1.064. Based on the equity, the company is underpriced. +1
  • The TTM is 1.064. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD1.046MRQ1.064-0.018
MRQ1.064TTM1.0640.000
TTM1.064YOY0.883+0.180
TTM1.0645Y1.397-0.334
5Y1.39710Y1.172+0.226
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Ckd Bio compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---4516.074-4516.0740%-2495.802-45%-898.192-80%-15.487-100%
Book Value Per Share--22425.32522425.3250%26941.399-17%27689.803-19%26132.504-14%
Current Ratio--1.1331.1330%1.513-25%1.739-35%2.300-51%
Debt To Asset Ratio--0.5810.5810%0.527+10%0.459+27%0.347+68%
Debt To Equity Ratio--1.3881.3880%1.115+24%0.901+54%0.605+129%
Dividend Per Share----0%100.000-100%134.801-100%193.628-100%
Eps---4409.897-4409.8970%-3044.610-31%-1057.224-76%35.650-12470%
Free Cash Flow Per Share---3281.516-3281.5160%-1902.086-42%-5242.721+60%-3502.706+7%
Free Cash Flow To Equity Per Share---3281.516-3281.5160%2647.577-224%-579.921-82%-432.019-87%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--79867.611--------
Intrinsic Value_10Y_min---60855.640--------
Intrinsic Value_1Y_max---899.145--------
Intrinsic Value_1Y_min---5514.331--------
Intrinsic Value_3Y_max--4083.124--------
Intrinsic Value_3Y_min---17172.154--------
Intrinsic Value_5Y_max--17245.080--------
Intrinsic Value_5Y_min---29402.403--------
Market Cap128645762000.000-2%130840146000.000130840146000.0000%130565871800.000+0%218176674280.000-40%172314026962.894-24%
Net Profit Margin---0.151-0.1510%-0.107-29%-0.033-78%0.010-1575%
Operating Margin----0%-0.0950%0.0000%0.045-100%
Operating Ratio--2.0762.0760%1.987+4%1.878+11%1.819+14%
Pb Ratio1.046-2%1.0641.0640%0.883+20%1.397-24%1.172-9%
Pe Ratio-5.318+2%-5.408-5.4080%-7.817+45%7.143-176%-0.813-85%
Price Per Share23450.000-2%23850.00023850.0000%23800.000+0%39770.000-40%31410.000-24%
Price To Free Cash Flow Ratio-7.146+2%-7.268-7.2680%-12.513+72%-8.242+13%-10.743+48%
Price To Total Gains Ratio-5.193+2%-5.281-5.2810%-9.934+88%-0.002-100%-1.313-75%
Quick Ratio--0.3460.3460%0.416-17%0.580-40%0.881-61%
Return On Assets---0.082-0.0820%-0.053-35%-0.017-80%0.009-1027%
Return On Equity---0.197-0.1970%-0.113-43%-0.047-76%-0.001-99%
Total Gains Per Share---4516.074-4516.0740%-2395.802-47%-763.390-83%178.141-2635%
Usd Book Value--86117106.57986117106.5790%103459626.116-17%106333621.387-19%100353317.785-14%
Usd Book Value Change Per Share---3.161-3.1610%-1.747-45%-0.629-80%-0.011-100%
Usd Book Value Per Share--15.69815.6980%18.859-17%19.383-19%18.293-14%
Usd Dividend Per Share----0%0.070-100%0.094-100%0.136-100%
Usd Eps---3.087-3.0870%-2.131-31%-0.740-76%0.025-12470%
Usd Free Cash Flow---12601585.094-12601585.0940%-7304340.358-42%-20132953.610+60%-9415698.028-25%
Usd Free Cash Flow Per Share---2.297-2.2970%-1.331-42%-3.670+60%-2.452+7%
Usd Free Cash Flow To Equity Per Share---2.297-2.2970%1.853-224%-0.406-82%-0.302-87%
Usd Market Cap90052033.400-2%91588102.20091588102.2000%91396110.260+0%152723671.996-40%120619818.874-24%
Usd Price Per Share16.415-2%16.69516.6950%16.660+0%27.839-40%21.987-24%
Usd Profit---16934763.748-16934763.7480%-11691830.934-31%-4059924.149-76%136900.993-12470%
Usd Revenue--112246944.845112246944.8450%109229628.928+3%100858474.045+11%90244599.438+24%
Usd Total Gains Per Share---3.161-3.1610%-1.677-47%-0.534-83%0.125-2635%
 EOD+3 -5MRQTTM+0 -0YOY+5 -295Y+7 -2710Y+6 -29

3.2. Fundamental Score

Let's check the fundamental score of Ckd Bio based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-5.318
Price to Book Ratio (EOD)Between0-11.046
Net Profit Margin (MRQ)Greater than0-0.151
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.346
Current Ratio (MRQ)Greater than11.133
Debt to Asset Ratio (MRQ)Less than10.581
Debt to Equity Ratio (MRQ)Less than11.388
Return on Equity (MRQ)Greater than0.15-0.197
Return on Assets (MRQ)Greater than0.05-0.082
Total2/10 (20.0%)

3.3. Technical Score

Let's check the technical score of Ckd Bio based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5046.507
Ma 20Greater thanMa 5023,897.500
Ma 50Greater thanMa 10023,570.000
Ma 100Greater thanMa 20023,015.500
OpenGreater thanClose23,800.000
Total4/5 (80.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2019-12-312020-12-312021-12-312022-12-312023-12-31
Other Current Assets  596,6651,466,7742,063,439-2,003,33860,1004,288,1154,348,215-4,348,2150
Other Current Liabilities  25,729,224-11,878,83413,850,390-4,669,2729,181,1181,125,92810,307,046-10,307,047-1



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in KRW. All numbers in thousands.

Summary
Total Assets293,785,061
Total Liabilities170,760,623
Total Stockholder Equity123,024,438
 As reported
Total Liabilities 170,760,623
Total Stockholder Equity+ 123,024,438
Total Assets = 293,785,061

Assets

Total Assets293,785,061
Total Current Assets111,768,693
Long-term Assets182,016,368
Total Current Assets
Cash And Cash Equivalents 3,630,222
Short-term Investments 69,549
Net Receivables 34,042,801
Inventory 69,082,221
Total Current Assets  (as reported)111,768,693
Total Current Assets  (calculated)106,824,792
+/- 4,943,901
Long-term Assets
Property Plant Equipment 172,509,133
Intangible Assets 6,137,561
Long-term Assets  (as reported)182,016,368
Long-term Assets  (calculated)178,646,694
+/- 3,369,675

Liabilities & Shareholders' Equity

Total Current Liabilities98,618,040
Long-term Liabilities72,142,584
Total Stockholder Equity123,024,438
Total Current Liabilities
Short Long Term Debt 75,785,236
Accounts payable 6,684,262
Other Current Liabilities -1
Total Current Liabilities  (as reported)98,618,040
Total Current Liabilities  (calculated)82,469,497
+/- 16,148,542
Long-term Liabilities
Long term Debt 69,431,181
Capital Lease Obligations Min Short Term Debt1,710,300
Long-term Liabilities Other 0
Long-term Liabilities  (as reported)72,142,584
Long-term Liabilities  (calculated)71,141,481
+/- 1,001,103
Total Stockholder Equity
Retained Earnings 79,317,685
Total Stockholder Equity (as reported)123,024,438
Total Stockholder Equity (calculated)79,317,685
+/- 43,706,753
Other
Capital Stock13,714,905
Common Stock Shares Outstanding 5,486
Net Debt 141,586,195
Net Invested Capital 268,240,855
Net Working Capital 13,150,654
Property Plant and Equipment Gross 358,395,871



Balance Sheet

Currency in KRW. All numbers in thousands.

 Trend2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-31
> Total Assets 
94,850,024
111,260,253
118,267,533
198,292,672
185,424,863
175,499,039
165,068,245
170,642,857
180,911,872
179,483,384
184,519,529
233,347,513
283,462,940
298,540,308
312,590,995
293,785,061
293,785,061312,590,995298,540,308283,462,940233,347,513184,519,529179,483,384180,911,872170,642,857165,068,245175,499,039185,424,863198,292,672118,267,533111,260,25394,850,024
   > Total Current Assets 
57,688,067
66,247,652
63,017,974
86,683,581
79,486,939
76,606,965
72,802,477
76,656,236
87,531,543
84,219,380
78,263,900
80,041,894
88,382,395
104,342,019
123,464,272
111,768,693
111,768,693123,464,272104,342,01988,382,39580,041,89478,263,90084,219,38087,531,54376,656,23672,802,47776,606,96579,486,93986,683,58163,017,97466,247,65257,688,067
       Cash And Cash Equivalents 
9,144,371
15,601,293
11,623,407
3,297,609
17,169,830
10,347,477
10,326,052
10,403,729
14,948,846
15,702,188
11,950,453
4,492,643
1,463,274
3,465,826
4,655,287
3,630,222
3,630,2224,655,2873,465,8261,463,2744,492,64311,950,45315,702,18814,948,84610,403,72910,326,05210,347,47717,169,8303,297,60911,623,40715,601,2939,144,371
       Short-term Investments 
0
0
0
2,304,000
0
0
360,000
0
1,944,000
5,988,000
4,855,741
71,582
69,992
69,025
8,069,210
69,549
69,5498,069,21069,02569,99271,5824,855,7415,988,0001,944,0000360,000002,304,000000
       Net Receivables 
20,719,870
27,011,751
28,810,769
50,381,176
29,829,619
28,695,101
30,743,088
30,853,049
30,218,473
27,515,058
31,055,013
43,160,394
23,985,637
29,095,177
25,896,679
34,042,801
34,042,80125,896,67929,095,17723,985,63743,160,39431,055,01327,515,05830,218,47330,853,04930,743,08828,695,10129,829,61950,381,17628,810,76927,011,75120,719,870
       Inventory 
25,411,509
22,771,275
21,837,987
30,105,648
31,873,291
37,131,137
30,958,381
35,074,117
38,610,662
33,243,819
28,402,449
31,437,574
59,111,388
70,355,877
78,506,850
69,082,221
69,082,22178,506,85070,355,87759,111,38831,437,57428,402,44933,243,81938,610,66235,074,11730,958,38137,131,13731,873,29130,105,64821,837,98722,771,27525,411,509
       Other Current Assets 
2,392,939
779,205
643,766
595,148
614,199
122,762
135,671
62,595
0
1
1,342,199
596,665
2,063,439
60,100
4,348,215
0
04,348,21560,1002,063,439596,6651,342,1991062,595135,671122,762614,199595,148643,766779,2052,392,939
   > Long-term Assets 
0
0
0
0
0
0
0
0
93,380,329
95,264,004
106,255,629
153,305,619
195,080,545
194,198,289
189,126,723
182,016,368
182,016,368189,126,723194,198,289195,080,545153,305,619106,255,62995,264,00493,380,32900000000
       Property Plant Equipment 
33,635,290
40,987,522
50,557,913
110,124,579
104,105,997
96,561,154
89,949,587
91,053,205
92,846,057
93,544,216
104,101,440
150,832,034
191,189,259
191,152,805
181,508,878
172,509,133
172,509,133181,508,878191,152,805191,189,259150,832,034104,101,44093,544,21692,846,05791,053,20589,949,58796,561,154104,105,997110,124,57950,557,91340,987,52233,635,290
       Long Term Investments 
318,600
18,600
1,740,600
24,600
360,600
912,600
1,104,600
1,536,600
24,600
24,600
7,200
7,200
0
0
0
0
00007,2007,20024,60024,6001,536,6001,104,600912,600360,60024,6001,740,60018,600318,600
       Intangible Assets 
249,678
198,017
141,976
217,742
140,927
76,037
56,322
49,237
42,703
1,223,898
1,920,269
2,211,038
2,920,970
2,772,960
3,839,018
6,137,561
6,137,5613,839,0182,772,9602,920,9702,211,0381,920,2691,223,89842,70349,23756,32276,037140,927217,742141,976198,017249,678
       Long-term Assets Other 
0
0
0
0
0
0
0
0
93,380,329
95,264,004
106,255,629
0
0
0
0
0
00000106,255,62995,264,00493,380,32900000000
> Total Liabilities 
45,697,444
47,183,360
42,127,237
79,289,079
61,277,558
51,624,969
43,223,103
43,266,946
45,747,557
37,437,454
36,857,869
74,884,901
114,714,927
137,048,970
164,791,529
170,760,623
170,760,623164,791,529137,048,970114,714,92774,884,90136,857,86937,437,45445,747,55743,266,94643,223,10351,624,96961,277,55879,289,07942,127,23747,183,36045,697,444
   > Total Current Liabilities 
43,132,234
44,202,636
39,556,998
58,294,060
41,390,338
33,440,802
28,512,326
28,234,173
33,817,443
26,825,877
23,635,809
45,023,564
46,114,065
44,310,728
81,590,584
98,618,040
98,618,04081,590,58444,310,72846,114,06545,023,56423,635,80926,825,87733,817,44328,234,17328,512,32633,440,80241,390,33858,294,06039,556,99844,202,63643,132,234
       Short-term Debt 
0
301,680
961,392
0
0
17,175,727
56,400
56,400
10,865,420
5,907,005
2,856,614
7,456,400
0
0
0
0
00007,456,4002,856,6145,907,00510,865,42056,40056,40017,175,72700961,392301,6800
       Short Long Term Debt 
0
301,680
961,392
0
0
17,175,727
56,400
56,400
10,865,420
5,907,005
2,856,614
7,456,400
19,247,055
19,321,036
56,299,880
75,785,236
75,785,23656,299,88019,321,03619,247,0557,456,4002,856,6145,907,00510,865,42056,40056,40017,175,72700961,392301,6800
       Accounts payable 
12,282,875
16,719,078
17,696,567
33,102,659
17,240,687
11,599,505
9,688,135
7,888,055
8,420,613
9,734,975
5,788,461
7,030,231
7,821,841
9,946,189
8,231,542
6,684,262
6,684,2628,231,5429,946,1897,821,8417,030,2315,788,4619,734,9758,420,6137,888,0559,688,13511,599,50517,240,68733,102,65917,696,56716,719,07812,282,875
       Other Current Liabilities 
5,907,186
8,209,406
6,605,186
387,847
1,070,695
4,133,569
4,813,178
7,580,784
168,871
229,309
11,826,770
25,729,224
13,850,390
9,181,118
10,307,046
-1
-110,307,0469,181,11813,850,39025,729,22411,826,770229,309168,8717,580,7844,813,1784,133,5691,070,695387,8476,605,1868,209,4065,907,186
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
11,930,114
10,611,577
13,222,059
29,861,337
68,600,862
92,738,242
83,200,945
72,142,584
72,142,58483,200,94592,738,24268,600,86229,861,33713,222,05910,611,57711,930,11400000000
       Capital Lease Obligations Min Short Term Debt
0
-301,680
-961,392
0
0
-17,175,727
-56,400
-56,400
-10,865,420
-5,907,005
-2,856,614
-5,536,584
1,397,278
789,424
2,252,142
1,710,300
1,710,3002,252,142789,4241,397,278-5,536,584-2,856,614-5,907,005-10,865,420-56,400-56,400-17,175,72700-961,392-301,6800
       Long-term Liabilities Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000
       Deferred Long Term Liability 
277,178
204,557
131,937
0
0
6,944
0
0
0
1,189,686
15,054
342,000
0
0
0
0
0000342,00015,0541,189,6860006,94400131,937204,557277,178
> Total Stockholder Equity
49,152,580
64,076,893
76,140,296
119,003,593
124,147,305
123,874,070
121,845,142
127,375,911
135,164,315
142,045,930
147,661,660
158,462,612
168,748,013
161,491,338
147,799,466
123,024,438
123,024,438147,799,466161,491,338168,748,013158,462,612147,661,660142,045,930135,164,315127,375,911121,845,142123,874,070124,147,305119,003,59376,140,29664,076,89349,152,580
   Common Stock
13,073,723
13,073,723
13,073,723
13,073,723
13,073,723
13,073,723
13,073,723
13,073,723
13,073,723
13,073,723
13,073,723
13,073,723
13,714,905
13,714,905
13,714,905
0
013,714,90513,714,90513,714,90513,073,72313,073,72313,073,72313,073,72313,073,72313,073,72313,073,72313,073,72313,073,72313,073,72313,073,72313,073,723
   Retained Earnings 
8,737,629
23,614,190
36,421,065
80,181,368
85,325,080
85,051,845
83,022,917
88,553,687
96,342,091
103,223,705
109,239,434
120,039,069
125,918,697
118,865,552
103,800,230
79,317,685
79,317,685103,800,230118,865,552125,918,697120,039,069109,239,434103,223,70596,342,09188,553,68783,022,91785,051,84585,325,08080,181,36836,421,06523,614,1908,737,629
   Accumulated Other Comprehensive Income 0000000000000000
   Capital Surplus 0000000000000000
   Treasury Stock0000000000000000



Balance Sheet

Currency in KRW. All numbers in thousands.




Cash Flow

Currency in KRW. All numbers in thousands.




Income Statement

Currency in KRW. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue160,352,778
Cost of Revenue-152,340,004
Gross Profit8,012,7748,012,774
 
Operating Income (+$)
Gross Profit8,012,774
Operating Expense-180,505,299
Operating Income-20,152,521-172,492,525
 
Operating Expense (+$)
Research Development14,979,912
Selling General Administrative6,586,090
Selling And Marketing Expenses-
Operating Expense180,505,29921,566,002
 
Net Interest Income (+$)
Interest Income374,340
Interest Expense-4,988,555
Other Finance Cost-21,338
Net Interest Income-4,635,553
 
Pretax Income (+$)
Operating Income-20,152,521
Net Interest Income-4,635,553
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-24,196,618-20,152,521
EBIT - interestExpense = -4,988,555
-24,192,520
-19,203,965
Interest Expense4,988,555
Earnings Before Interest and Taxes (EBIT)--19,208,063
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax-24,196,618
Tax Provision--4,098
Net Income From Continuing Ops-24,192,520-24,192,520
Net Income-24,192,520
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net-4,635,553
 

Technical Analysis of Ckd Bio
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Ckd Bio. The general trend of Ckd Bio is BULLISH with 42.9% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Ckd Bio's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (42.9%) Bearish trend (-42.9%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Ckd Bio.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 23,850 < 25,700 < 25,850.

The bearish price targets are: 23,000 > 22,750 > 22,600.

Tweet this
Ckd Bio Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Ckd Bio. The current mas is .

The long score for the Moving Averages is 10/14.
The longshort score for the Moving Averages is 6/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Ckd Bio Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Ckd Bio. The current macd is -106.12286273.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Ckd Bio price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Ckd Bio. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Ckd Bio price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Ckd Bio Daily Moving Average Convergence/Divergence (MACD) ChartCkd Bio Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Ckd Bio. The current adx is 18.55.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -1/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Ckd Bio shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Ckd Bio Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Ckd Bio. The current sar is 24,181.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Ckd Bio Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Ckd Bio. The current rsi is 46.51. The current phase is Correction in bull market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

  • Correction in bull market: Moderate price decline, potential pause in the uptrend. Reassess the market, wait for signs of stabilization.
  • Trending down: The RSI is trending down. -1
Ckd Bio Daily Relative Strength Index (RSI) ChartCkd Bio Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Ckd Bio. The current phase is Correction in bull market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -4/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Ckd Bio price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Ckd Bio Daily Stochastic Oscillator ChartCkd Bio Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Ckd Bio. The current cci is -56.92108668.

Ckd Bio Daily Commodity Channel Index (CCI) ChartCkd Bio Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Ckd Bio. The current cmo is -9.76318412.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Ckd Bio Daily Chande Momentum Oscillator (CMO) ChartCkd Bio Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Ckd Bio. The current willr is -54.83870968.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Ckd Bio is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Ckd Bio Daily Williams %R ChartCkd Bio Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Ckd Bio.

Ckd Bio Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Ckd Bio. The current atr is 671.65.

Ckd Bio Daily Average True Range (ATR) ChartCkd Bio Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Ckd Bio. The current obv is 4,602,534.

Ckd Bio Daily On-Balance Volume (OBV) ChartCkd Bio Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Ckd Bio. The current mfi is 42.63.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Ckd Bio Daily Money Flow Index (MFI) ChartCkd Bio Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Ckd Bio.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-24STOCH SHORT EXITThe %K line crosses above the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2023-11-27MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2023-11-29MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-11-30CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-04STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-05CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-07MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-08STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-11ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-15STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-18MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-21STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-22STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-26CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-12-28WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-01-03STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-01-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-12MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-01-16CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-17DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-19DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-01-22STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-24STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-29CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-30CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-31STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-01DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-06CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-08DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-02-13STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-15STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-16WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-21SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-22CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-23MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-02-26MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-02-27STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-05STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-06CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-03-08BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-11WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-13STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-14STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-19WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-20STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-03-22STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-03-25WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-27MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-29WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-02SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-03DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-04-05STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-04-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-11STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-12STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-15DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-04-16STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-18STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-19DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside

6.3. Candlestick Patterns

Ckd Bio Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Ckd Bio based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5046.507
Ma 20Greater thanMa 5023,897.500
Ma 50Greater thanMa 10023,570.000
Ma 100Greater thanMa 20023,015.500
OpenGreater thanClose23,800.000
Total4/5 (80.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Ckd Bio with someone you think should read this too:
  • Are you bullish or bearish on Ckd Bio? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Ckd Bio? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Ckd Bio

I send you an email if I find something interesting about Ckd Bio.


Comments

How you think about this?

Leave a comment

Stay informed about Ckd Bio.

Receive notifications about Ckd Bio in your mailbox!